Global Biofilms Treatment Market, By Product (Debridement Equipment, Gauzes and Dressings, Grafts and Matrices, Wipes, Pads, and Lavage Solutions, Gels, Ointments, and Sprays), Wound Type (Surgical and Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burns and Other Open Wounds), End User (Hospitals, ASCS, and Wound Care Centers, Home Care Settings; Other End Users) – Industry Trends and Forecast to 2029.
Biofilms Treatment Market Analysis and Size
A growing number of wounds and hospital-acquired infections have increased the demand for biofilms treatment in the healthcare industry. In order to prevent contamination, biofilms treatment is required because implanted devices like catheters and pacemakers are the primary sites for biofilm growth. According to the survey, approximately 60% to 70% of chronic wounds have biofilms inside them. This element is predicted to accelerate market growth.
Data Bridge Market Research analyses that the biofilms treatment market which was USD 1.73 billion in 2021, would rocket up to USD 3.02 billion by 2029, and is expected to undergo a CAGR of 7.2% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Biofilms Treatment Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Product (Debridement Equipment; Gauzes and Dressings; Grafts and Matrices; Wipes, Pads, and Lavage Solutions; Gels, Ointments, and Sprays), Wound Type (Surgical and Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Burns and Other Open Wounds), End User (Hospitals, ASCS, and Wound Care Centers, Home Care Settings, Other End Users
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Smith+Nephew (U.K.), MiMedx (U.S.), ConvaTec Group plc (U.K.), Coloplast Group (Denmark), Mölnlycke Healthcare AB (Sweden), Organogenesis Inc. (U.S.), Integra LifeSciences (U.S.), B. Braun Melsungen AG (Germany), PAUL HARTMANN AG (Germany), Medline Industries Inc. (U.k.), Acelity (U.S.), Misonix (U.S.), Zimmer Biomet (U.S.), Kerecis (Iceland), Welcare Industries S.p.A (Italy)
The term "biofilm" refers to a group of microorganisms that live on diverse surfaces. Bacteria, protists, and fungi are the microorganisms that cause a biofilm to form. On animal tissues, pacemakers, implanted medical equipment including catheters, and plant tissues, biofilms can be seen. Biofilms may develop on the earth's surface, in groundwater, on minerals, or on metals.
Biofilms Treatment Market Dynamics
- Rising number of patients
The factors such as the rising number of patients with surgical and chronic wounds, the ageing population, the prevalence of enhanced treatment options, and the prevalence of diabetes and obesity are projected to boost the growth of the biofilms treatment market in the forecast period of 2022–2029. On the other hand, growing applications from emerging nations will further raise a number of chances that will drive the market for the treatment of biofilms during the forecast period.
- Growing number of wounds and hospital-acquired infections
A growing number of wounds and hospital-acquired infections have increased the demand for biofilm in the healthcare industry. In order to prevent contamination, biofilm treatment is required because implanted devices like catheters and pacemakers are the primary sites for biofilm growth. According to the survey, approximately 60% to 70% of chronic wounds have biofilms inside of them. This element is predicted to accelerate market growth.
- Government rules
Government-imposed standards and restrictions designed to prevent contamination in a healthy person are probably going to spur market expansion. For example, strict guidelines and criteria have been enforced by the european society for clinical microbiology and infectious disease to detect and treat infectious diseases brought by biofilm. This aspect could increase demand for biofilm removal in forecast period.
On the other hand, the surging treatment cost and low penetration rate of wound care products will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
This biofilms treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biofilms treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- In May 2020, ConvaTec announced the release of ConvaMax, which aids in the management of highly draining wounds such as leg ulcers, surgical wounds, and diabetic foot ulcers.
Global Biofilms Treatment Market Scope
The biofilms treatment market is segmented on the basis of product, wound type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Debridement Equipment
- Gauzes and Dressings
- Grafts and Matrices
- Wipes, Pads
- Lavage Solutions
- Surgical and Traumatic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Burns and Other Open Wounds
- Wound Care Centers
- Home Care Settings
- Other End Users
Biofilms Treatment Market Regional Analysis/Insights
The biofilms treatment market is analysed and market size insights and trends are provided by country, product, wound type and end user as referenced above.
The countries covered in the biofilms treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biofilms treatment market due to the increasing healthcare expenditure, rising occurrences of chronic wounds, adoption of speciality biofilm management products along with prevalence of majority of market vendors in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to growing prevalence of biofilms on medical devices such as implantable devices leading to failure of the treatment, along with rising diabetic foot ulcers and wound injuries is expected to boost the biofilms treatment market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Biofilms Treatment Market Share Analysis
The biofilms treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biofilms treatment market.
Some of the major players operating in the biofilms treatment market are:
- Smith+Nephew (U.K.)
- MiMedx (U.S.)
- ConvaTec Group plc (U.K.)
- Coloplast Group (Denmark)
- Mölnlycke Healthcare AB (Sweden)
- Organogenesis Inc. (U.S.)
- Integra LifeSciences (U.S.)
- B. Braun Melsungen AG (Germany)
- PAUL HARTMANN AG (Germany)
- Medline Industries Inc. (U.K.)
- Acelity (U.S.)
- Misonix (U.S.)
- Zimmer Biomet (U.S.)
- Kerecis (Iceland)
- Welcare Industries S.p.A (Italy)